CY1107603T1 - Χρηση της ανθρωπινης ορμονης αναπτυξης για την αυξηση του αριθμου των κυκλοφορουντων κυτταρων cd34+, με στοχο την ανασυνθεση των αιματοποιητικων και ανοσοποιητικων συστηματων ακολουθωντας μυελοβλαστικες ή αντιβλαστικες θepαπειες, μεσω μεταμοσχευσης, επαναμεταγγισης ή εμφυτευσης - Google Patents
Χρηση της ανθρωπινης ορμονης αναπτυξης για την αυξηση του αριθμου των κυκλοφορουντων κυτταρων cd34+, με στοχο την ανασυνθεση των αιματοποιητικων και ανοσοποιητικων συστηματων ακολουθωντας μυελοβλαστικες ή αντιβλαστικες θepαπειες, μεσω μεταμοσχευσης, επαναμεταγγισης ή εμφυτευσηςInfo
- Publication number
- CY1107603T1 CY1107603T1 CY20071100021T CY071100021T CY1107603T1 CY 1107603 T1 CY1107603 T1 CY 1107603T1 CY 20071100021 T CY20071100021 T CY 20071100021T CY 071100021 T CY071100021 T CY 071100021T CY 1107603 T1 CY1107603 T1 CY 1107603T1
- Authority
- CY
- Cyprus
- Prior art keywords
- hematopoietic
- growth hormone
- thepapeies
- myelovlastikes
- epanametangisis
- Prior art date
Links
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 title abstract 3
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 title abstract 3
- 230000003394 haemopoietic effect Effects 0.000 title abstract 3
- 102000002265 Human Growth Hormone Human genes 0.000 title abstract 2
- 108010000521 Human Growth Hormone Proteins 0.000 title abstract 2
- 239000000854 Human Growth Hormone Substances 0.000 title abstract 2
- 210000000777 hematopoietic system Anatomy 0.000 title 1
- 210000000987 immune system Anatomy 0.000 title 1
- 238000002513 implantation Methods 0.000 title 1
- 238000002054 transplantation Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98124834A EP1016413A1 (en) | 1998-12-30 | 1998-12-30 | Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells |
| EP99965579A EP1140149B1 (en) | 1998-12-30 | 1999-12-30 | Use of human growth hormone to increase the number of circulating cd34+ cells, intended for reconstitution of the hematopoietic and immune systems following myeloablative or antiblastic therapies, by transplantation, re-infusion or engraftment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1107603T1 true CY1107603T1 (el) | 2013-03-13 |
Family
ID=8233268
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20071100021T CY1107603T1 (el) | 1998-12-30 | 2007-01-08 | Χρηση της ανθρωπινης ορμονης αναπτυξης για την αυξηση του αριθμου των κυκλοφορουντων κυτταρων cd34+, με στοχο την ανασυνθεση των αιματοποιητικων και ανοσοποιητικων συστηματων ακολουθωντας μυελοβλαστικες ή αντιβλαστικες θepαπειες, μεσω μεταμοσχευσης, επαναμεταγγισης ή εμφυτευσης |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20060029581A1 (https=) |
| EP (3) | EP1016413A1 (https=) |
| JP (1) | JP4808316B2 (https=) |
| AT (1) | ATE342064T1 (https=) |
| AU (2) | AU772222B2 (https=) |
| BR (1) | BR9916726A (https=) |
| CA (1) | CA2354194A1 (https=) |
| CY (1) | CY1107603T1 (https=) |
| DE (1) | DE69933581T2 (https=) |
| DK (1) | DK1140149T3 (https=) |
| ES (1) | ES2275359T3 (https=) |
| IL (2) | IL143994A0 (https=) |
| PT (1) | PT1140149E (https=) |
| SI (1) | SI1140149T1 (https=) |
| WO (1) | WO2000040260A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003535144A (ja) * | 2000-06-07 | 2003-11-25 | アプライド・リサーチ・システムズ・エイアールエス・ホールディング・ナムローゼ・フェンノートシャップ | 多能性造血幹細胞の流動を刺激するヒト成長ホルモン |
| CA2417356A1 (en) | 2000-08-01 | 2002-02-07 | Yissum Research Development Company | Directed differentiation of embryonic cells |
| ES2380009T3 (es) * | 2001-07-31 | 2012-05-07 | Genzyme Global S.A.R.L. | Métodos para movilizar las células madre/progenitoras |
| CA2540529C (en) * | 2003-10-03 | 2012-03-13 | Vib Vzw | Means and methods for the recruitment and identification of stem cells |
| JP2005289837A (ja) * | 2004-03-31 | 2005-10-20 | Juntendo | 骨髄細胞誘導剤の製造方法及び製造装置 |
| US7816320B2 (en) * | 2004-12-22 | 2010-10-19 | Ambrx, Inc. | Formulations of human growth hormone comprising a non-naturally encoded amino acid at position 35 |
| JP2013515081A (ja) * | 2009-12-21 | 2013-05-02 | アンブルックス，インコーポレイテッド | 修飾されているブタのソマトトロピンポリペプチドおよびそれらの使用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5649904A (en) * | 1988-10-07 | 1997-07-22 | Sandoz Ltd. | Method of treating cancer with a fully myeloablative regimen of chemotherapy, radiation or both |
| US5199942A (en) * | 1991-06-07 | 1993-04-06 | Immunex Corporation | Method for improving autologous transplantation |
| EP0563485A1 (en) * | 1992-03-30 | 1993-10-06 | Schering-Plough | In vitro generation of human dendritic cells and uses thereof |
| DE69430059T2 (de) * | 1993-06-15 | 2002-11-14 | British Biotech Pharmaceuticals Ltd., Cowley | Freisetzung und Mobilisierung hämatopoietischer Zellen |
| JPH07101877A (ja) * | 1993-10-04 | 1995-04-18 | Mitsui Toatsu Chem Inc | 血小板減少症治療剤 |
| DE69433967D1 (de) * | 1993-10-06 | 2004-09-30 | Univ Florida | Stammzellen-proliferations-faktor |
| JPH0892001A (ja) * | 1994-09-26 | 1996-04-09 | Asahi Medical Co Ltd | 細胞集団の保存方法 |
| EP0871458B1 (en) * | 1995-07-21 | 2002-11-20 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment |
| EP0877795A4 (en) * | 1996-01-16 | 2003-03-05 | Depuy Orthopaedics Inc | INSULATION OF PROCUREMENT CELLS FROM HEMATOPOIETIC AND NON-HEMATOPOIETIC TISSUES AND THEIR USE |
| JP4042925B2 (ja) * | 1996-11-20 | 2008-02-06 | シスメックス株式会社 | 幼若白血球の分類計数法 |
| JPH10295369A (ja) * | 1997-02-26 | 1998-11-10 | Japan Tobacco Inc | 造血幹細胞の製造方法 |
| SE9804064D0 (sv) * | 1998-11-25 | 1998-11-25 | A & Science Invest Ab | Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells |
| DE69919969T2 (de) * | 1998-12-17 | 2005-09-29 | Applied Research Systems Ars Holding N.V. | Humanes Wachstumshormon zur Stimulierung der Hämatopoese und der Immunrekonstitution nach hämatopoetischer Stammzelltransplantation beim Menschen |
| JP2003535144A (ja) * | 2000-06-07 | 2003-11-25 | アプライド・リサーチ・システムズ・エイアールエス・ホールディング・ナムローゼ・フェンノートシャップ | 多能性造血幹細胞の流動を刺激するヒト成長ホルモン |
| US7220407B2 (en) * | 2003-10-27 | 2007-05-22 | Amgen Inc. | G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction |
-
1998
- 1998-12-30 EP EP98124834A patent/EP1016413A1/en not_active Withdrawn
-
1999
- 1999-12-30 WO PCT/EP1999/010470 patent/WO2000040260A1/en not_active Ceased
- 1999-12-30 DK DK99965579T patent/DK1140149T3/da active
- 1999-12-30 PT PT99965579T patent/PT1140149E/pt unknown
- 1999-12-30 IL IL14399499A patent/IL143994A0/xx unknown
- 1999-12-30 SI SI9930937T patent/SI1140149T1/sl unknown
- 1999-12-30 JP JP2000592015A patent/JP4808316B2/ja not_active Expired - Fee Related
- 1999-12-30 AT AT99965579T patent/ATE342064T1/de active
- 1999-12-30 ES ES99965579T patent/ES2275359T3/es not_active Expired - Lifetime
- 1999-12-30 EP EP06021178A patent/EP1779865A1/en not_active Withdrawn
- 1999-12-30 DE DE69933581T patent/DE69933581T2/de not_active Expired - Lifetime
- 1999-12-30 CA CA002354194A patent/CA2354194A1/en not_active Abandoned
- 1999-12-30 AU AU21039/00A patent/AU772222B2/en not_active Ceased
- 1999-12-30 BR BR9916726-3A patent/BR9916726A/pt not_active Application Discontinuation
- 1999-12-30 EP EP99965579A patent/EP1140149B1/en not_active Expired - Lifetime
-
2001
- 2001-06-26 IL IL143994A patent/IL143994A/en not_active IP Right Cessation
-
2004
- 2004-07-22 AU AU2004203355A patent/AU2004203355B2/en not_active Ceased
-
2005
- 2005-09-29 US US11/237,876 patent/US20060029581A1/en not_active Abandoned
-
2007
- 2007-01-08 CY CY20071100021T patent/CY1107603T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000040260A1 (en) | 2000-07-13 |
| AU2103900A (en) | 2000-07-24 |
| JP2002534393A (ja) | 2002-10-15 |
| US20060029581A1 (en) | 2006-02-09 |
| JP4808316B2 (ja) | 2011-11-02 |
| IL143994A0 (en) | 2002-04-21 |
| DE69933581T2 (de) | 2007-06-21 |
| AU2004203355B2 (en) | 2007-05-17 |
| EP1140149B1 (en) | 2006-10-11 |
| AU772222B2 (en) | 2004-04-22 |
| EP1779865A1 (en) | 2007-05-02 |
| ATE342064T1 (de) | 2006-11-15 |
| EP1016413A1 (en) | 2000-07-05 |
| SI1140149T1 (sl) | 2007-02-28 |
| DK1140149T3 (da) | 2007-02-19 |
| IL143994A (en) | 2009-06-15 |
| AU2004203355A1 (en) | 2004-08-19 |
| DE69933581D1 (de) | 2006-11-23 |
| EP1140149A1 (en) | 2001-10-10 |
| BR9916726A (pt) | 2001-09-11 |
| CA2354194A1 (en) | 2000-07-13 |
| PT1140149E (pt) | 2007-01-31 |
| ES2275359T3 (es) | 2007-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1107603T1 (el) | Χρηση της ανθρωπινης ορμονης αναπτυξης για την αυξηση του αριθμου των κυκλοφορουντων κυτταρων cd34+, με στοχο την ανασυνθεση των αιματοποιητικων και ανοσοποιητικων συστηματων ακολουθωντας μυελοβλαστικες ή αντιβλαστικες θepαπειες, μεσω μεταμοσχευσης, επαναμεταγγισης ή εμφυτευσης | |
| MX9705954A (es) | Formulaciones y metodos para reducir irritacion de la piel. | |
| ATE286118T1 (de) | Anwendungen für humane nicht autologe, mesenchymale stammzellen | |
| MX9705710A (es) | Compuestos con propiedades de liberacion de la hormona del crecimiento. | |
| BRPI0413002A (pt) | genes de ciclo de célula de planta e métodos de uso | |
| DK240088D0 (da) | Fremgangsmaade til transformation af et plantecellematerale | |
| DK516386A (da) | Hybride bakterier | |
| ATE265220T1 (de) | Kostimulatorische blockade und gemischter chimerismus in allotransplantationen | |
| EP2278022A3 (en) | Expression vectors, transfection systems, and method of use thereof | |
| ATE444078T1 (de) | Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen | |
| BR112021019349A2 (pt) | Células-tronco preparadas altamente funcionais | |
| DK0885229T3 (da) | Kondenserede pyrrolo[2,3-c]carbazol-6-oner, der potenserer aktivitet af gamma-interferon | |
| FR2662698B1 (https=) | ||
| JOP20220204B1 (ar) | الأجسام المضادة لـ cd19 البشرية | |
| FR2749022B1 (fr) | Cellules aviaires immortelles | |
| ATE226087T1 (de) | Verwendung von neuen zelltod inducierenden mitteln im synergismus mit interferon | |
| AU4751797A (en) | Defined systems for epithelial cell culture and use thereof | |
| DK0793503T3 (da) | Anvendelse af hepatocyt-vækstfaktor til inducering af profilerering og differentiering af hemotopoietiske celler | |
| YU63291A (sh) | Hibridni kalcitonin | |
| DK0765398T3 (da) | Population af celler, der er beriget for myeloide og/eller lymfoide progenitorer og fremgangsmåde til fremstilling og anvendelse deraf | |
| ATE278461T1 (de) | Mikropartikel hergestellt aus cycloolefincopolymeren und deren verwendung zur kontrollierten wirkstofffreigabe | |
| IT9048066A0 (it) | 2- amminotetraline-6, 7-sostituite attive come immunomodulanti e composizioni farmaceutiche che le contengono. | |
| IL110585A0 (en) | Tripeptides, their preparation and pharmaceutical compositions containing them | |
| ATE311886T1 (de) | Verwendung einer zusammensetzung enthaltend 5- androsten-3beta,17alpha-diol | |
| PT1016414E (pt) | Hormona de crescimento humano para estimular a hematopoiese e a reconstituicao imnologica apos transplante de celulas estaminais hematopoieticas em humanos |